2011
DOI: 10.1039/c1ic90027g
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of metal complexes with nucleic acids

Abstract: This chapter, divided into three sections, reviews the literature reported during 2010 in the field of interaction of metal complexes with nucleic acids and complex formation between metals and coordinating moieties within nucleic acids. The first two sections focus on the interaction of metal complexes and ions with DNA and RNA, respectively, and are organised by mode of interaction. In the last section examples where transition metals occupy coordination sites covalently incorporated within nucleic acids str… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 96 publications
0
2
0
Order By: Relevance
“…Nowadays, an active research area is focused on the development of new metallodrugs capable of interacting with DNA, and organometallic ruthenium complexes are promising candidates to this aim. Over the past few years, a huge amount of work has been published on the synthesis, cytotoxicity, and DNA binding ability of this type of compounds; in particular, clinical trials have been done on NAMI-A and KP1019, whose action is based on the activation by reduction of Ru(III) to Ru(II). Moreover, synthesized Ru(II) arene complexes such as RM175 or RAPTA-T have shown both in vitro and in vivo anticancer activity.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, an active research area is focused on the development of new metallodrugs capable of interacting with DNA, and organometallic ruthenium complexes are promising candidates to this aim. Over the past few years, a huge amount of work has been published on the synthesis, cytotoxicity, and DNA binding ability of this type of compounds; in particular, clinical trials have been done on NAMI-A and KP1019, whose action is based on the activation by reduction of Ru(III) to Ru(II). Moreover, synthesized Ru(II) arene complexes such as RM175 or RAPTA-T have shown both in vitro and in vivo anticancer activity.…”
Section: Introductionmentioning
confidence: 99%
“…Investigations on DNA cleavage and developments of efficient chemical nucleases have attracted wide interest owing to their potential applications as promising therapeutic agents as well as diagnostic structural probes to analyze DNA information. Among all the chemical nucleases reported so far, transition metal complexes have obvious advantages because metal complexes with natural cationic character particularly favor the redox, hydrolysis and other photoreactions, thus leading to strong affinity to DNA 59,60 . For example, [Cu(phen) 2 ] + units have been widely studied as chemical nucleases for highly efficient DNA cleavage since the redox properties of the metal could not only promote the reactive oxygen species (ROS) generation but also have strong noncovalent interactions with DNA 61 .…”
Section: Resultsmentioning
confidence: 99%